Filing Details
- Accession Number:
- 0001140361-15-041198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-13 16:49:54
- Reporting Period:
- 2015-11-11
- Filing Date:
- 2015-11-13
- Accepted Time:
- 2015-11-13 16:49:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1332456 | Barry Labinger | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Biosciences Div. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-11-11 | 6,564 | $35.51 | 30,229 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-11 | 9,373 | $28.09 | 39,602 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-11 | 9,373 | $35.50 | 30,229 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-11 | 10,095 | $20.94 | 40,324 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-11 | 10,095 | $35.50 | 30,229 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-12 | 10,094 | $20.94 | 40,323 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-12 | 10,094 | $36.00 | 30,229 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-11 | 1,671 | $35.88 | 28,558 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2015-11-11 | 9,373 | $0.00 | 9,373 | $28.09 |
| Common Stock | Stock Option | Disposition | 2015-11-11 | 10,095 | $0.00 | 10,095 | $20.94 |
| Common Stock | Stock Option | Disposition | 2015-11-12 | 10,094 | $0.00 | 10,094 | $20.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-03-11 | 2021-03-10 | No | 4 | M | Direct |
| 0 | 2013-11-11 | 2020-11-11 | No | 4 | M | Direct |
| 0 | 2013-11-11 | 2020-11-11 | No | 4 | M | Direct |
Footnotes
- Consists of an option granted under the company's stock incentive plan on March 11, 2014.
- Consists of an option granted under the company's stock incentive plan on November 12, 2013.
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50-$35.59, inclusive.
Billionaire Hedge Funds
